John J. Turner

754 total citations
18 papers, 554 citations indexed

About

John J. Turner is a scholar working on Molecular Biology, Surgery and Virology. According to data from OpenAlex, John J. Turner has authored 18 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Virology. Recurrent topics in John J. Turner's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (8 papers) and DNA and Nucleic Acid Chemistry (7 papers). John J. Turner is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (8 papers) and DNA and Nucleic Acid Chemistry (7 papers). John J. Turner collaborates with scholars based in United Kingdom, United States and France. John J. Turner's co-authors include Michael J. Gait, Simon W. Jones, Andrey Arzumanov, Martin M. Fabani, Sterghios Moschos, Mark A. Lindsay, David Owen, Donna Williams, Gabriela D. Ivanova and Bernard Lebleu and has published in prestigious journals such as Nucleic Acids Research, Annals of the New York Academy of Sciences and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

John J. Turner

17 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John J. Turner United Kingdom 10 507 87 86 34 26 18 554
Edwige Gros France 6 545 1.1× 37 0.4× 118 1.4× 19 0.6× 39 1.5× 10 626
Lyuba Benimetskaya United States 12 515 1.0× 41 0.5× 46 0.5× 19 0.6× 18 0.7× 15 676
Maggie Bobbin United States 4 385 0.8× 89 1.0× 42 0.5× 27 0.8× 47 1.8× 5 475
Shinichiro Nakagawa Japan 10 329 0.6× 76 0.9× 68 0.8× 11 0.3× 23 0.9× 23 522
Hadi Al Shamaileh Australia 9 401 0.8× 101 1.2× 28 0.3× 16 0.5× 117 4.5× 9 522
Thierry Arnould France 14 820 1.6× 34 0.4× 264 3.1× 32 0.9× 59 2.3× 21 943
Hsu-Kun Wang United States 10 159 0.3× 53 0.6× 51 0.6× 18 0.5× 26 1.0× 23 483
Nicole McNeer United States 10 460 0.9× 41 0.5× 56 0.7× 6 0.2× 21 0.8× 15 526
Gabriela D. Ivanova United Kingdom 11 668 1.3× 41 0.5× 138 1.6× 4 0.1× 30 1.2× 19 715
Françoise Illien France 13 374 0.7× 37 0.4× 35 0.4× 10 0.3× 16 0.6× 24 448

Countries citing papers authored by John J. Turner

Since Specialization
Citations

This map shows the geographic impact of John J. Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Turner more than expected).

Fields of papers citing papers by John J. Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Turner. The network helps show where John J. Turner may publish in the future.

Co-authorship network of co-authors of John J. Turner

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Turner. A scholar is included among the top collaborators of John J. Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Turner. John J. Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Turner, John J. & Brian Rinker. (2014). Melanoma of the Hand: Current Practice and New Frontiers. Healthcare. 2(1). 125–138. 5 indexed citations
2.
Turner, John J., et al.. (2011). Methods for L-ribooligonucleotide sequence determination using LCMS. Nucleic Acids Research. 39(21). e147–e147. 13 indexed citations
3.
Overhoff, Marita, Winfried Wünsche, John J. Turner, et al.. (2009). Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide. RNA. 15(4). 627–636. 42 indexed citations
4.
Ivanova, Gabriela D., Andrey Arzumanov, John J. Turner, et al.. (2008). RNA targeting in cells by peptide conjugates of peptide nucleic acids (PNA). 103–111. 3 indexed citations
5.
Abes, Saïd, John J. Turner, Gabriela D. Ivanova, et al.. (2007). Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Research. 35(13). 4495–4502. 118 indexed citations
6.
Abes, Saïd, John J. Turner, Paul Prévôt, et al.. (2007). Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides. International Journal of Pharmaceutics. 344(1-2). 96–102. 17 indexed citations
7.
Turner, John J., Simon W. Jones, Sterghios Moschos, Mark A. Lindsay, & Michael J. Gait. (2006). MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity. Molecular BioSystems. 3(1). 43–50. 123 indexed citations
8.
Turner, John J., et al.. (2006). RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Molecules and Diseases. 38(1). 1–7. 122 indexed citations
9.
Arzumanov, Andrey, John J. Turner, Sandrine Reigadas, et al.. (2006). Anti‐HIV Activity of Steric Block Oligonucleotides. Annals of the New York Academy of Sciences. 1082(1). 103–115. 5 indexed citations
10.
Turner, John J., Donna Williams, David Owen, & Michael J. Gait. (2006). Disulfide Conjugation of Peptides to Oligonucleotides and Their Analogs. Current Protocols in Nucleic Acid Chemistry. 24(1). Unit 4.28–Unit 4.28. 28 indexed citations
11.
Fabani, Martin M., John J. Turner, & Michael J. Gait. (2006). Oligonucleotide analogs as antiviral agents.. PubMed. 8(2). 108–14. 9 indexed citations
12.
Selgin, George & John J. Turner. (2006). JAMES WATT AS INTELLECTUAL MONOPOLIST: COMMENT ON BOLDRIN AND LEVINE*. International Economic Review. 47(4). 1341–1348. 6 indexed citations
13.
Turner, John J., et al.. (2005). Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: Chemistry and cell delivery. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758(3). 290–300. 30 indexed citations
14.
Brown, Douglas, Andrey Arzumanov, John J. Turner, et al.. (2005). ANTIVIRAL ACTIVITY OF STERIC-BLOCK OLIGONUCLEOTIDES TARGETING THE HIV-1 TRANS-ACTIVATION RESPONSE AND PACKAGING SIGNAL STEM-LOOP RNAS. Nucleosides Nucleotides & Nucleic Acids. 24(5-7). 393–396. 13 indexed citations
15.
Turner, John J., et al.. (2004). Novel Reversed Chain Modified Oligopeptides via Sequential α-N-Mitsunobu Condensation of a Functionalized C-glycoside. Chemistry Letters. 33(4). 468–469. 1 indexed citations
16.
Kasirajan, Karthikeshwar, Mark K. Hirko, John J. Turner, & Jeffrey R. Rubin. (1999). Is the Use of Suboptimal Saphenous Veins Justifiable for Limb Salvage?. Vascular Surgery. 33(2). 157–162.
17.
Kasirajan, Karthikeshwar, Robert J. Obermeyer, Maria Lucarelli, et al.. (1998). Calciphylaxis: Calcific Angiopathy Resulting in Acral Gangrene. Vascular Surgery. 32(5). 447–453. 3 indexed citations
18.
Moss, Ronald B., F. Ferré, Alexandra M. Levine, et al.. (1996). Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy. Journal of Clinical Immunology. 16(5). 266–271. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026